Leptin and mucosal immunity

Mucosal Immunology

Volumn 5, Issue 5, 2012, Pages 472-479

  Mackey Lawrence, N M ^a   Petri, W A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; INTERLEUKIN 22; LEPTIN; LEPTIN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT3 PROTEIN;

ALLELE; AMEBIASIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXOME; GENETIC ASSOCIATION; HORMONE SUBSTITUTION; HOST PATHOGEN INTERACTION; HUMAN; INFECTION RESISTANCE; INTRACELLULAR SIGNALING; KLEBSIELLA PNEUMONIAE INFECTION; LEPTIN DEFICIENCY; MOLECULAR PATHOLOGY; MUCOSAL IMMUNITY; MUTATIONAL ANALYSIS; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

EID: 84865362879     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.40     Document Type: Review

References (90)

1. Das, U. N. Obesity: genes, brain, gut, and environment. Nutrition 26, 459-473 (2010
2. Myers, M. G., Cowley, M. A. & Munzberg, H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70, 537-556 (2008
3. Leinninger, G. M. & Myers, M. G. Jr. LRb signals act within a distributed network of leptin-responsive neurones to mediate leptin action. Acta. Physiol. (Oxf.) 192, 49-59 (2008
4. Myers, M. G. Jr. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog. Horm. Res. 59, 287-304 (2004
5. Lago, R., Gomez, R., Lago, F., Gomez-Reino, J. & Gualillo, O. Leptin beyond body weight regulation-current concepts concerning its role in immune function and infl ammation. Cell Immunol. 252, 139-145 (2008
6. Faggioni, R., Feingold, K. R. & Grunfeld, C. Leptin regulation of the immune response and the immunodefi ciency of malnutrition. FASEB J. 15, 2565-2571 (2001
7. Fantuzzi, G. & Faggioni, R. Leptin in the regulation of immunity, infl ammation, and hematopoiesis. J. Leukoc. Biol. 68, 437-446 (2000
8. Sitaraman, S. et al. Colonic leptin: source of a novel proinfl ammatory cytokine involved in IBD. FASEB J. 18, 696-698 (2004
9. De Rosa, V. et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241-255 (2007
10. Fernandez-Riejos, P. et al. Role of leptin in the activation of immune cells. Mediators Infl amm. 2010, 568343 (2010
11. Otero, M. et al. Towards a pro-infl ammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45, 944-950 (2006
12. Farooqi, I. S. et al. Benefi cial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin defi ciency. J. Clin. Invest. 110, 1093-1103 (2002
13. Duggal, P. et al. Leptin mediates mucosal immunity to Entamoeba histolytica infection in children. J. Clin. Invest. 121, 1191-1198 (2010
14. Guo, X. et al. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol. 4, 294-303 (2010
15. Lemos, M. P., Rhee, K. Y. & McKinney, J. D. Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression. J. Immunol. 187, 3776-3784 (2011
16. Moore, S. I., Huffnagle, G. B., Chen, G. H., White, E. S. & Mancuso, P. Leptin modulates neutrophil phagocytosis of Klebsiella pneumoniae. Infect. Immun. 71, 4182-4185 (2003
17. Hsu, A., Aronoff, D. M., Phipps, J., Goel, D. & Mancuso, P. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin. Exp. Immunol. 150, 332-339 (2007
18. Mancuso, P., Huffnagle, G. B., Olszewski, M. A., Phipps, J. & Peters-Golden, M. Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 173, 212-218 (2006
19. Petri, W. A. Jr, Mondal, D., Peterson, K. M., Duggal, P. & Haque, R. Association of malnutrition with amebiasis. Nutr. Rev. 67 (Suppl 2), S207-S215 (2009
20. Clement, K. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398-401 (1998
21. Farooqi, I. S. et al. Clinical and molecular genetic spectrum of congenital defi ciency of the leptin receptor. N. Engl. J. Med. 356, 237-247 (2007
22. Gibson, W. T. et al. Congenital leptin defi ciency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J. Clin. Endocrinol. Metab. 89, 4821-4826 (2004
23. Montague, C. T. et al. Congenital leptin defi ciency is associated with severe early-onset obesity in humans. Nature 387, 903-908 (1997
24. Ozata, M., Ozdemir, I. C. & Licinio, J. Human leptin defi ciency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3695 (1999
25. Bluher, S., Shah, S. & Mantzoros, C. S. Leptin defi ciency: clinical implications and opportunities for therapeutic interventions. J. Investig. Med. 57, 784-788 (2009
26. Kimber, W. et al. Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor. Endocrinology 149, 6043-6052 (2008
27. Palacio, A., Lopez, M., Perez-Bravo, F., Monkeberg, F. & Schlesinger, L. Leptin levels are associated with immune response in malnourished infants. J. Clin. Endocrinol. Metab. 87, 3040-3046 (2002
28. Fraser, D. A., Thoen, J., Reseland, J. E., Forre, O. & Kjeldsen-Kragh, J. Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin. Rheumatol. 18, 394-401 (1999
29. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R. & Lechler, R. I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901 (1998
30. Mancuso, P., Canetti, C., Gottschalk, A., Tithof, P. K. & Peters-Golden, M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L497-L502 (2004
31. Sanchez-Margalet, V. & Martin-Romero, C. Human leptin signaling in human peripheral blood mononuclear cells: Activation of the JAK-STAT pathway. Cell. Immunol. 211, 30-36 (2001
32. Hansen, G. H., Niels-Christiansen, L. L. & Danielsen, E. M. Leptin and the obesity receptor (OB-R) in the small intestine and colon: A colocalization study. J. Histochem. Cytochem. 56, 677-685 (2008
33. Fruhbeck, G. Intracellular signalling pathways activated by leptin. Biochem. J. 393 (Pt 1), 7-20 (2006
34. Suzukawa, M. et al. Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J. Immunol. 186, 5254-5260 (2011
35. Barrenetxe, J. et al. Distribution of the long leptin receptor isoform in brush border, basolateral membrane, and cytoplasm of enterocytes. Gut 50, 797-802 (2002
36. Wrann, C. D. et al. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am. J. Physiol. Endocrinol. Metab. 302, E108-E116 (2012
37. Kanda, N. & Watanabe, S. Leptin enhances human beta-defensin-2 production in human keratinocytes. Endocrinology 149, 5189-5198 (2008
38. Villanueva, E. C. & Myers, M. G. Jr Leptin receptor signaling and the regulation of mammalian physiology. Int. J. Obes. (Lond.) 32 (Suppl 7), S8-S12 (2008
39. Pai, R., Lin, C., Tran, T. & Tarnawski, A. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochem. Biophys. Res. Commun. 331, 984-992 (2005
40. Ogunwobi, O. O. & Beales, I. L. The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int. J. Colorectal Dis. 22, 401-409 (2007
41. Marie, C. S., Verkerke, H. P., Paul, S. N., Mackey, A. J. & Petri, W. A. Jr. Leptin protects host cells from Entamoeba histolytica cytotoxicity by a STAT-3 dependent mechanism. Infect. Immun. 226, 2123-2130 (2012
42. Siegmund, B., Lehr, H. A. & Fantuzzi, G. Leptin: A pivotal mediator of intestinal infl ammation in mice. Gastroenterology 122, 2011-2025 (2002
43. Padidar, S. et al. Leptin upregulates pro-infl ammatory cytokines in discrete cells within mouse colon. J. Cell. Physiol. 226, 2123-2130 (2010
44. Mancuso, P. et al. Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia. J. Immunol. 186, 1081-1090 (2011
45. Exome Variant Server In: (ESP) NESP (ed). Seattle, WA.
46. WHO. WHO News and Activities: Entamoeba Taxonomy, 291-292 (1997
47. Ghosh, P. K., Gupta, S., Naik, S., Ayyagari, A. & Naik, S. R. Effect of bacterial association on virulence of Entamoeba histolytica to baby hamster kidney cell monolayers. Indian J. Exp. Biol. 36, 911-915 (1998
48. Variyam, E. P. Luminal host-defense mechanisms against invasive amebiasis. Trends Parasitol. 23, 108-111 (2007
49. Baxt, L. A. & Singh, U. New insights into Entamoeba histolytica pathogenesis. Curr. Opin. Infect. Dis. 21, 489-494 (2008
50. Pritt, B. S. & Clark, C. G. Amebiasis. Mayo Clin. Proc. 83, 1154-1159; quiz 1159-1160 (2008
51. Mortimer, L. & Chadee, K. The immunopathogenesis of Entamoeba histolytica. Exp. Parasitol. 126, 366-380 (2010
52. Mondal, D., Haque, R., Sack, R. B., Kirkpatrick, B. D. & Petri, W. A. Jr. Attribution of malnutrition to cause-specifi c diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am. J. Trop. Med. Hyg. 80, 824-826 (2009
53. Bruno, A., Conus, S., Schmid, I. & Simon, H. U. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J. Immunol. 174, 8090-8096 (2005
54. Sukhotnik, I. et al. Leptin affects intestinal epithelial cell turnover in correlation with leptin receptor expression along the villus-crypt axis after massive small bowel resection in a rat. Pediatr. Res. 66, 648-653 (2009
55. Sukhotnik, I. et al. Leptin accelerates enterocyte turnover during methotrexate-induced intestinal mucositis in a rat. Cancer Biol. Ther. 8, 899-906 (2009
56. Peterson, K. et al. The role of the intestinal epithelial protein REG 1 in protection from Entamoeba histolytica colitis. Infect. Immun. 60, 296-300 (2010
57. Plaisancie, P. et al. Luminal leptin activates mucin-secreting goblet cells in the large bowel. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G805-G812 (2006
58. El Homsi, M. et al. Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G365-G373 (2007
59. Han, X. et al. Regulation of intestinal barrier function by signal transducer and activator of transcription 5b. Gut 58, 49-58 (2009
60. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R. & Gordon, J. I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006
61. Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D. & Gordon, J. I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102, 11070-11075 (2005
62. Abolhassani, M. et al. Leptin receptor-related immune response in colorectal tumors: The role of colonocytes and interleukin-8. Cancer Res. 68, 9423-9432 (2008
63. Hruz, P., Dann, S. M. & Eckmann, L. STAT3 and its activators in intestinal defense and mucosal homeostasis. Curr. Opin. Gastroenterol. 26, 109-115 (2010
64. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022 (2009
65. Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991 (2009
66. Rutz, S. & Ouyang, W. Regulation of interleukin-10 and interleukin-22 expression in T helper cells. Curr. Opin. Immunol. 23, 605-612 (2011
67. Neurath, M. F. New therapies for sepsis: focus on the interleukin (IL)12 family member IL27. Ann Rheum. Dis. 66 (Suppl 3), iii29-iii31 (2007
68. Diegelmann, J., Olszak, T., Goke, B., Blumberg, R. S. & Brand, S. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-infl ammatory proteins. J. Biol. Chem. 287, 286-298 (2012
69. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009
70. Jones, S. A., Scheller, J. & Rose-John, S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J. Clin. Invest. 121, 3375-3383 (2011
71. Li, Y. et al. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 59, 227-235 (2010
72. Dambacher, J. et al. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in infl ammatory bowel disease. Gut 56, 1257-1265 (2007
73. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008
74. Ma, L. J., Acero, L. F., Zal, T. & Schluns, K. S. Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8alphaalpha IELs. J. Immunol. 183, 1044-1054 (2009
75. Caruso, R. et al. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology 132, 166-175 (2007
76. Denning, T. L. et al. Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int. Immunol. 12, 133-139 (2000
77. Ropeleski, M. J., Tang, J., Walsh-Reitz, M. M., Musch, M. W. & Chang, E. B. Interleukin-11-induced heat shock protein 25 confers intestinal epithelialspecifi c cytoprotection from oxidant stress. Gastroenterology 124, 1358-1368 (2003
78. Reinecker, H. C. & Podolsky, D. K. Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 92, 8353-8357 (1995
79. Waldmann, T. A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595-601 (2006
80. Paul, W. E. Fundamental Immunology, 6th edn. (Wolters Kluwer/Lippincott Williams & Wilkins: Philadelphia, 2008) xviii, 1603 p., 1616 p. of platespp.
81. Holland, S. M. et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357, 1608-1619 (2007
82. Freeman, A. F. & Holland, S. M. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr. Res. 65 (5 Pt 2), 32R-37R (2009
83. Levy, D. E. & Loomis, C. A. STAT3 signaling and the hyper-IgE syndrome. N. Engl. J. Med. 357, 1655-1658 (2007
84. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009
85. Taube, C. et al. IL-22 is produced by innate lymphoid cells and limits infl ammation in allergic airway disease. PLoS One 6, e21799 (2011
86. Wilson, M. S. et al. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184, 4378-4390 (2010
87. Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S. & Flavell, R. A. Innate and adaptive interleukin-22 protects mice from infl ammatory bowel disease. Immunity 29, 947-957 (2008
88. Black, R. E. et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371, 243-260 (2008
89. Karlsson, E. A. & Beck, M. A. The burden of obesity on infectious disease. Exp. Biol. Med. (Maywood) 235, 1412-1424 (2010
90. Stienstra, R. et al. Infl ammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 108, 15324-15329 (2011